Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
35
MED Quote, Financials, Valuation and Earnings
Last price:
$16.87
Seasonality move
:
-3.81%
Day range:
$16.73 - $17.47
52-week range:
$16.73 - $70.58
Dividend yield:
0%
P/E ratio:
27.74x
P/S ratio:
0.27x
P/B ratio:
0.89x
Volume:
482.5K
Avg. volume:
230.5K
1-year change:
-74.75%
Market cap:
$185.1M
Revenue:
$1.1B
EPS (TTM):
$0.61
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $713.7M | $934.8M | $1.5B | $1.6B | $1.1B | |
| Revenue Growth (YoY) | 42.45% | 30.99% | 63.25% | 4.75% | -32.94% | |
| Cost of Revenues | $176.8M | $237M | $398.5M | $458.2M | $296.2M | |
| Gross Profit | $536.9M | $697.8M | $1.1B | $1.1B | $775.9M | |
| Gross Profit Margin | 75.23% | 74.65% | 73.89% | 71.34% | 72.37% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $445.8M | $563.7M | $911.4M | $955.6M | $649.4M | |
| Other Inc / (Exp) | $29K | -$140K | $119K | -$46K | -$95K | |
| Operating Expenses | $445.8M | $563.7M | $911.4M | $955.6M | $649.4M | |
| Operating Income | $91M | $134.2M | $216.2M | $184.8M | $126.4M | |
| Net Interest Expenses | -- | -- | $231K | $701K | -- | |
| EBT. Incl. Unusual Items | $92.4M | $134.3M | $216.1M | $184.1M | $128.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $14.4M | $31.4M | $52.1M | $40.5M | $29.4M | |
| Net Income to Company | $77.9M | $102.9M | $164M | $143.6M | $99.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $77.9M | $102.9M | $164M | $143.6M | $99.4M | |
| Basic EPS (Cont. Ops) | $6.62 | $8.74 | $14.01 | $12.82 | $9.13 | |
| Diluted EPS (Cont. Ops) | $6.43 | $8.68 | $13.89 | $12.73 | $9.10 | |
| Weighted Average Basic Share | $11.8M | $11.8M | $11.7M | $11.2M | $10.9M | |
| Weighted Average Diluted Share | $12.1M | $11.9M | $11.8M | $11.3M | $10.9M | |
| EBITDA | $95.7M | $138.5M | $223.1M | $195.7M | $139.5M | |
| EBIT | $91M | $134.2M | $216.2M | $184.8M | $126.4M | |
| Revenue (Reported) | $713.7M | $934.8M | $1.5B | $1.6B | $1.1B | |
| Operating Income (Reported) | $91M | $134.2M | $216.2M | $184.8M | $126.4M | |
| Operating Income (Adjusted) | $91M | $134.2M | $216.2M | $184.8M | $126.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $271.5M | $413.4M | $390.4M | $235.9M | $140.2M | |
| Revenue Growth (YoY) | 42.83% | 52.28% | -5.56% | -39.58% | -40.58% | |
| Cost of Revenues | $67.4M | $106.3M | $107.5M | $58.5M | $34.5M | |
| Gross Profit | $204M | $307.1M | $282.8M | $177.4M | $105.7M | |
| Gross Profit Margin | 75.16% | 74.28% | 72.45% | 75.2% | 75.39% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $159.5M | $251.9M | $234.7M | $151.9M | $103.6M | |
| Other Inc / (Exp) | $30K | $115K | -$17K | $7K | -$1.9M | |
| Operating Expenses | $159.5M | $251.9M | $234.7M | $151.9M | $103.6M | |
| Operating Income | $44.6M | $55.2M | $48.2M | $25.5M | $2.1M | |
| Net Interest Expenses | -- | $94K | $261K | -- | -- | |
| EBT. Incl. Unusual Items | $44.6M | $55.2M | $47.9M | $26.5M | $1.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $10.2M | $13.2M | $11.7M | $3.4M | $449K | |
| Net Income to Company | $34.5M | $42M | $36.2M | $23.1M | $1.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $34.5M | $42M | $36.2M | $23.1M | $1.1M | |
| Basic EPS (Cont. Ops) | $2.93 | $3.59 | $3.30 | $2.12 | $0.10 | |
| Diluted EPS (Cont. Ops) | $2.91 | $3.56 | $3.27 | $2.12 | $0.10 | |
| Weighted Average Basic Share | $11.8M | $11.7M | $11M | $10.9M | $10.9M | |
| Weighted Average Diluted Share | $11.9M | $11.8M | $11M | $10.9M | $11M | |
| EBITDA | $46.3M | $56.6M | $51M | $28.9M | $5.3M | |
| EBIT | $44.6M | $55.3M | $48.2M | $25.5M | $2.1M | |
| Revenue (Reported) | $271.5M | $413.4M | $390.4M | $235.9M | $140.2M | |
| Operating Income (Reported) | $44.6M | $55.2M | $48.2M | $25.5M | $2.1M | |
| Operating Income (Adjusted) | $44.6M | $55.3M | $48.2M | $25.5M | $2.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $840.6M | $1.4B | $1.6B | $1.2B | $674.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $213.9M | $364.6M | $454.1M | $350.2M | $176.7M | |
| Gross Profit | $626.6M | $1B | $1.2B | $868.1M | $497.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $511.7M | $841.2M | $986.1M | $717.8M | $486.9M | |
| Other Inc / (Exp) | $52K | -$40K | -$30K | -$54K | -$3.6M | |
| Operating Expenses | $511.7M | $841.2M | $986.1M | $717.8M | $486.9M | |
| Operating Income | $114.9M | $207.4M | $199M | $150.3M | $10.8M | |
| Net Interest Expenses | -- | $104K | $613K | -- | -- | |
| EBT. Incl. Unusual Items | $115.4M | $207.2M | $198.4M | $151.4M | $12.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $20.7M | $49.2M | $47.3M | $31.5M | $5M | |
| Net Income to Company | $94.7M | $158M | $151.1M | $119.9M | $7.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $94.7M | $158M | $151.1M | $119.9M | $7.3M | |
| Basic EPS (Cont. Ops) | $8.07 | $13.46 | $13.30 | $11.03 | $0.61 | |
| Diluted EPS (Cont. Ops) | $7.99 | $13.34 | $13.19 | $10.99 | $0.61 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $120.2M | $211.2M | $210M | $163M | $23.7M | |
| EBIT | $114.9M | $207.5M | $198.9M | $150.3M | $10.8M | |
| Revenue (Reported) | $840.6M | $1.4B | $1.6B | $1.2B | $674.5M | |
| Operating Income (Reported) | $114.9M | $207.4M | $199M | $150.3M | $10.8M | |
| Operating Income (Adjusted) | $114.9M | $207.5M | $198.9M | $150.3M | $10.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $669.9M | $1.1B | $1.3B | $881M | $483.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $171.4M | $298.9M | $354.5M | $246.6M | $127.1M | |
| Gross Profit | $498.6M | $849.3M | $906.8M | $634.5M | $356.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $402.4M | $679.9M | $754.6M | $516.8M | $354.2M | |
| Other Inc / (Exp) | $12K | $112K | -$37K | -$45K | -$3.5M | |
| Operating Expenses | $402.4M | $679.9M | $754.6M | $516.8M | $354.2M | |
| Operating Income | $96.2M | $169.4M | $152.2M | $117.7M | $2.2M | |
| Net Interest Expenses | -- | $161K | $520K | $181K | -- | |
| EBT. Incl. Unusual Items | $96.4M | $169.4M | $151.7M | $119M | $2.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $21.6M | $39.4M | $34.6M | $25.6M | $1.2M | |
| Net Income to Company | $74.9M | $130M | $117.1M | $93.4M | $1.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $74.9M | $130M | $117M | $93.4M | $1.3M | |
| Basic EPS (Cont. Ops) | $6.36 | $11.08 | $10.36 | $8.58 | $0.11 | |
| Diluted EPS (Cont. Ops) | $6.33 | $10.98 | $10.28 | $8.56 | $0.11 | |
| Weighted Average Basic Share | $35.3M | $35.2M | $33.9M | $32.6M | $32.8M | |
| Weighted Average Diluted Share | $35.5M | $35.5M | $34.1M | $32.7M | $32.9M | |
| EBITDA | $101.5M | $173.3M | $160.2M | $127.5M | $11.7M | |
| EBIT | $96.2M | $169.5M | $152.2M | $117.7M | $2.2M | |
| Revenue (Reported) | $669.9M | $1.1B | $1.3B | $881M | $483.5M | |
| Operating Income (Reported) | $96.2M | $169.4M | $152.2M | $117.7M | $2.2M | |
| Operating Income (Adjusted) | $96.2M | $169.5M | $152.2M | $117.7M | $2.2M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $77M | $163.7M | $104.2M | $87.7M | $94.4M | |
| Short Term Investments | $15.7M | $10.8M | $5.4M | -- | $55.6M | |
| Accounts Receivable, Net | $1.4M | -- | -- | -- | -- | |
| Inventory | $48.8M | $53.4M | $180M | $118.9M | $54.6M | |
| Prepaid Expenses | $11.3M | $6.4M | $945K | -- | $8.7M | |
| Other Current Assets | -- | -- | $16.3M | $16.2M | $10.7M | |
| Total Current Assets | $154.2M | $234.3M | $306.9M | $222.8M | $224M | |
| Property Plant And Equipment | $38.8M | $38.1M | $80.6M | $75.6M | $67.1M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $353K | $2.9M | $6.5M | $12.5M | $14.7M | |
| Total Assets | $194.7M | $276.1M | $398.3M | $316.2M | $309.9M | |
| Accounts Payable | $22.6M | $36.1M | $70.9M | $53.1M | $39.2M | |
| Accrued Expenses | $20.8M | $24.6M | $35.9M | $23.8M | $22.1M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $3.2M | $3.7M | $6.5M | $5.8M | $5.9M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $79.4M | $111.4M | $169.8M | $140.9M | $92.3M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $89.8M | $118.8M | $195.9M | $161.2M | $108.4M | |
| Common Stock | $12K | $12K | $12K | $11K | $11K | |
| Other Common Equity Adj | $25K | $41K | $111K | $24K | $248K | |
| Common Equity | $104.8M | $157.2M | $202.5M | $155M | $201.5M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $104.8M | $157.2M | $202.5M | $155M | $201.5M | |
| Total Liabilities and Equity | $194.7M | $276.1M | $398.3M | $316.2M | $309.9M | |
| Cash and Short Terms | $92.7M | $174.5M | $109.5M | $87.7M | $150M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $156.5M | $154.5M | $69.7M | $112.8M | $115.3M | |
| Short Term Investments | $13.4M | $5.4M | -- | $45M | $54.6M | |
| Accounts Receivable, Net | $647K | -- | -- | -- | -- | |
| Inventory | $41.7M | $129.6M | $145.3M | $58.2M | $40.1M | |
| Prepaid Expenses | $5.2M | $11.5M | $14.6M | -- | $8.2M | |
| Other Current Assets | -- | -- | -- | $8.3M | $6.7M | |
| Total Current Assets | $217.5M | $301.1M | $229.6M | $224.3M | $225M | |
| Property Plant And Equipment | $38.3M | $63.2M | $77.9M | $69.2M | $51.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $3M | $6.4M | $12.7M | $15.8M | $11M | |
| Total Assets | $260.8M | $371.4M | $326.4M | $320M | $291.2M | |
| Accounts Payable | -- | -- | -- | $103.2M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $3.3M | $5.4M | $6.1M | $5.5M | $6.1M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $112M | $160.9M | $154.3M | $110.1M | $72.4M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $120.8M | $175.1M | $175.8M | $127M | $83.9M | |
| Common Stock | $12K | $12K | $11K | $11K | $11K | |
| Other Common Equity Adj | $97K | $122K | $391K | $141K | $349K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $140M | $196.2M | $150.5M | $193M | $207.3M | |
| Total Liabilities and Equity | $260.8M | $371.4M | $326.4M | $320M | $291.2M | |
| Cash and Short Terms | $169.9M | $159.9M | $69.7M | $157.8M | $170M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $77.9M | $102.9M | $164M | $143.6M | $99.4M | |
| Depreciation & Amoritzation | $4.6M | $4.3M | $6.8M | $11M | $13.1M | |
| Stock-Based Compensation | $4.5M | $6.8M | $9.9M | $11.1M | $8.2M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$9.9M | -$4.6M | -$126.7M | $61.2M | $64.3M | |
| Cash From Operations | $84.3M | $145.2M | $94.5M | $194.6M | $147.7M | |
| Capital Expenditures | $10.1M | $5.9M | $34.2M | $16.7M | $6.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$6.3M | -$1.3M | -$29.1M | -$11.4M | -$61M | |
| Dividends Paid (Ex Special Dividend) | -$35.4M | -$53.2M | -$63.9M | -$71.6M | -$73M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$47.2M | -$5.6M | -$62.1M | -$128M | -$7M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$82.3M | -$57.1M | -$125.1M | -$199.6M | -$79.8M | |
| Beginning Cash (CF) | $81.4M | $77M | $163.7M | $104.2M | $87.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$4.4M | $86.8M | -$59.7M | -$16.4M | $6.8M | |
| Ending Cash (CF) | $77M | $163.7M | $104.2M | $87.7M | $94.4M | |
| Levered Free Cash Flow | $74.2M | $139.3M | $60.3M | $177.9M | $141.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $34.5M | $42M | $36.2M | $23.1M | $1.1M | |
| Depreciation & Amoritzation | $1.8M | $1.3M | $2.9M | $3.4M | $3.2M | |
| Stock-Based Compensation | $2.1M | $2.3M | $3M | $2.7M | $606K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$3.2M | -$33.8M | $11.7M | $10.7M | -$492K | |
| Cash From Operations | $41.1M | $15.8M | $55.4M | $29.9M | $9.1M | |
| Capital Expenditures | $3.3M | $10.4M | $1.8M | $1.7M | $1.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2.3M | -$10.4M | -$1.8M | -$46.5M | -$1.8M | |
| Dividends Paid (Ex Special Dividend) | -$13.3M | -$16.8M | -$18.1M | -$18M | -$1K | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -$27M | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$36K | -$26.3M | -$25K | -$110K | -$2K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$13.2M | -$42.9M | -$45.1M | -$18.2M | -$3K | |
| Beginning Cash (CF) | $130.8M | $192M | $61.1M | $147.4M | $108M | |
| Foreign Exchange Rate Adjustment | -$1K | $63K | $119K | $26K | $4K | |
| Additions / Reductions | $25.7M | -$37.5M | $8.5M | -$34.7M | $7.3M | |
| Ending Cash (CF) | $156.5M | $154.5M | $69.7M | $112.8M | $115.3M | |
| Levered Free Cash Flow | $37.8M | $5.4M | $53.6M | $28.3M | $7.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $94.7M | $158M | $151.1M | $119.9M | $7.3M | |
| Depreciation & Amoritzation | $4.8M | $2.8M | $11.1M | $12.7M | $12.9M | |
| Stock-Based Compensation | $5.3M | $9.2M | $11.4M | $8.7M | $7.6M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | $10.2M | -$87.9M | -$15.7M | $87.1M | $18.1M | |
| Cash From Operations | $144.5M | $121.8M | $135.4M | $188.9M | $39.9M | |
| Capital Expenditures | $4.7M | $24.6M | $19.2M | $14.6M | $6.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2.7M | -$16.9M | -$14M | -$59.4M | -$17.8M | |
| Dividends Paid (Ex Special Dividend) | -$48.6M | -$60.1M | -$70.7M | -$73M | -$18.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$19.3M | -$47.9M | -$135.8M | -$13.4M | -$845K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$66.5M | -$107M | -$206.5M | -$86.2M | -$19.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $75.3M | -$2.1M | -$85.1M | $43.3M | $2.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $139.8M | $97.2M | $116.1M | $174.3M | $33.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $74.9M | $130M | $117.1M | $93.4M | $1.3M | |
| Depreciation & Amoritzation | $5.3M | $3.8M | $8M | $9.8M | $9.5M | |
| Stock-Based Compensation | $4.2M | $6.6M | $8.1M | $5.8M | $5.2M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | $7M | -$76.2M | $34.8M | $60.6M | $14.5M | |
| Cash From Operations | $125.4M | $102M | $142.8M | $137.1M | $29.4M | |
| Capital Expenditures | $3.9M | $22.6M | $7.6M | $5.5M | $5.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.9M | -$17.4M | -$2.4M | -$50.3M | -$7.1M | |
| Dividends Paid (Ex Special Dividend) | -$39.9M | -$46.8M | -$53.7M | -$55M | -$715K | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$5.5M | -$47.9M | -$121.6M | -$7M | -$835K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$44M | -$93.9M | -$175.3M | -$61.9M | -$1.5M | |
| Beginning Cash (CF) | $298.5M | $561.7M | $283.3M | $358.8M | $299.9M | |
| Foreign Exchange Rate Adjustment | -$3K | $130K | $296K | $125K | $47K | |
| Additions / Reductions | $79.5M | -$9.3M | -$34.8M | $24.9M | $20.8M | |
| Ending Cash (CF) | $378M | $552.5M | $248.8M | $383.9M | $320.8M | |
| Levered Free Cash Flow | $121.5M | $79.4M | $135.2M | $131.6M | $24.3M | |
Get MED Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MED
Sector
P/E ratio
27.74x
17.73x
PEG ratio
--
0.35x
P/B ratio
0.89x
1.67x
Price / LTM sales
0.27x
0.69x
Growth Metrics
MED
Sector
Revenue growth
-40.58%
0.27%
Earnings growth
-95.28%
-3.16%
Revenue (5-year growth)
16.43%
4.3%
Earnings forecast
-$0.19
$0.31
Profitability
MED
Sector
Profitability FY 2023
$775.9M
$575.2M
Return on invested capital
3.6%
5.51%
Return on assets
2.41%
3.55%
Return on equity
3.6%
8.37%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Feb
20
Estimated Next Earnings Date
Feb
3
Balance Sheet
MED
Sector
Total cash
$170M
$163.2M
Short term investments
$55.6M
$53.7M
Total assets
$309.9M
$1.9B
Long term debt
--
$145.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
